ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pera, M.
Right arrow Articles by Pairolero, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pera, M.
Right arrow Articles by Pairolero, P. C.

The Annals of Thoracic Surgery, Vol 54, 199-204, Copyright © 1992 by The Society of Thoracic Surgeons


ARTICLES

Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?

M Pera, VF Trastek, HA Carpenter, MS Allen, C Deschamps and PC Pairolero
Department of Surgery, Mayo Clinic, Rochester, Minnesota.

Between 1982 and 1991, 19 patients (17 men and 2 women) with Barrett's esophagus, 10 of whom were in a surveillance program, were found to have high-grade dysplasia without evidence of invasive carcinoma. Median age was 66 years (range, 30 to 79 years). Heartburn was the most common presenting symptom. Esophagoscopy at the time of high-grade dysplasia diagnosis demonstrated normal Barrett's mucosa in 10 patients (53%), shallow ulcers in 3, slight mucosal irregularities in 2, small mucosal nodules in 2, stricture in 1, and shallow ulcer with stricture in 1. Eighteen patients underwent esophagectomy. There were no operative deaths. Nine patients (50%) had invasive carcinoma. Postsurgical stage was stage 0 in 9 patients, stage I in 6, stage IIA in 2, and stage IIB in 1. Median follow-up was 34 months (range, 2 to 116 months). Recurrent cancer developed in 2 patients. Overall 5-year survival was 66.7%; 5-year survival for patients with stage 0 disease was 100% and for stage I and II disease, 35.7%. We conclude that high- grade dysplasia in an indication for esophageal resection because of the high rate of associated early invasive carcinoma and that resection can be done safely with the expectation of excellent long-term survival. Because of these findings, we continue to recommend endoscopic surveillance in all patients with Barrett's esophagus.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
R D Odze
Diagnosis and grading of dysplasia in Barrett's oesophagus.
J. Clin. Pathol., October 1, 2006; 59(10): 1029 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
R. J. Moraca and D. E. Low
Outcomes and Health-Related Quality of Life After Esophagectomy for High-Grade Dysplasia and Intramucosal Cancer
Arch Surg, June 1, 2006; 141(6): 545 - 551.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Soetikno, T. Kaltenbach, R. Yeh, and T. Gotoda
Endoscopic Mucosal Resection for Early Cancers of the Upper Gastrointestinal Tract
J. Clin. Oncol., July 10, 2005; 23(20): 4490 - 4498.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. F. Reed, G. Tolis Jr, B. H. Edil, J. S. Allan, D. M. Donahue, H. A. Gaissert, A. C. Moncure, J. C. Wain, C. D. Wright, and D. J. Mathisen
Surgical Treatment of Esophageal High-Grade Dysplasia
Ann. Thorac. Surg., April 1, 2005; 79(4): 1110 - 1115.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N J Shaheen, J M Inadomi, B F Overholt, and P Sharma
What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis
Gut, December 1, 2004; 53(12): 1736 - 1744.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M S Dar, J R Goldblum, T W Rice, and G W Falk
Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?
Gut, April 1, 2003; 52(4): 486 - 489.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Inadomi, R. Sampliner, J. Lagergren, D. Lieberman, A M. Fendrick, and N. Vakil
Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis
Ann Intern Med, February 4, 2003; 138(3): 176 - 186.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A H Ormsby, R E Petras, W H Henricks, T W Rice, L A Rybicki, J E Richter, and J R Goldblum
Observer variation in the diagnosis of superficial oesophageal adenocarcinoma
Gut, November 1, 2002; 51(5): 671 - 676.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. R. Headrick, F. C. Nichols III, D. L. Miller, M. S. Allen, V. F. Trastek, C. Deschamps, C. D. Schleck, A. M. Thompson, and P. C. Pairolero
High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy
Ann. Thorac. Surg., June 1, 2002; 73(6): 1697 - 1703.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. Shaheen and D. F. Ransohoff
Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review
JAMA, April 17, 2002; 287(15): 1972 - 1981.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. F. Al-kasspooles, H. C. Hill, H. R. Nava, J. L. Smith, H. O. Douglass, and J. F. Gibbs
High-Grade Dysplasia Within Barrett's Esophagus: Controversies Regarding Clinical Opinions and Approaches
Ann. Surg. Oncol., April 1, 2002; 9(3): 222 - 227.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Walch, J. Mueller, H. Hofler, and M. Werner
Re: Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) Tissue
J Natl Cancer Inst, July 19, 2000; 92(14): 1182 - 1182.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. K. Walch, H. F. Zitzelsberger, J. Bruch, G. Keller, D. Angermeier, M. M. Aubele, J. Mueller, H. Stein, H. Braselmann, J. R. Siewert, et al.
Chromosomal Imbalances in Barrett’s Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence
Am. J. Pathol., February 1, 2000; 156(2): 555 - 566.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J W van Sandick, J J B van Lanschot, B W Kuiken, G N J Tytgat, G J A Offerhaus, and H Obertop
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma
Gut, August 1, 1998; 43(2): 216 - 222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T.-T. Wu, T. Watanabe, R. Heitmiller, M. Zahurak, A. A. Forastiere, and S. R. Hamilton
Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region
Am. J. Pathol., July 1, 1998; 153(1): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. J. Hoff, J. L. Sawyers, C. D. Blanke, H. Choy, and J. R. Stewart
Prognosis of Adenocarcinoma Arising in Barrett's Esophagus
Ann. Thorac. Surg., January 1, 1998; 65(1): 176 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. K. Ferguson and K. S. Naunheim
RESECTION FOR BARRETT'S MUCOSA WITH HIGH-GRADE DYSPLASIA: IMPLICATIONS FOR PROPHYLACTIC PHOTODYNAMIC THERAPY
J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 824 - 829.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
A. J. McLarty, C. Deschamps, V. F. Trastek, M. S. Allen, P. C. Pairolero, and W. S. Harmsen
Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life
Ann. Thorac. Surg., June 1, 1997; 63(6): 1568 - 1571.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
M. D. Iannettoni, S. S. Lee, M. R. Bonnell, T. L. Sell, R. I. Whyte, M. B. Orringer, and D. G. Beer
Detection of Barrett's Adenocarcinoma of the Gastric Cardia With Sucrase Isomaltase and p53
Ann. Thorac. Surg., November 1, 1996; 62(5): 1460 - 1465.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
E. A. Davis and R. F. Heitmiller
Esophagectomy for Benign Disease: Trends in Surgical Results and Management
Ann. Thorac. Surg., August 1, 1996; 62(2): 369 - 372.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
A. G. Little
Barrett's Esophagus
Ann. Thorac. Surg., July 1, 1996; 62(1): 315 - 315.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. L. McDonald, V. F. Trastek, M. S. Allen, C. Deschamps, and P. C. Pairolero
BARRETT'S ESOPHAGUS: DOES AN ANTIREFLUX PROCEDURE REDUCE THE NEED FOR ENDOSCOPIC SURVEILLANCE?
J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1135 - 1140.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. H. Peters, G. W. B. Clark, A. P. Ireland, P. Chandrasoma, T. C. Smyrk, and T. R. DeMeester
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 813 - 822.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Lerut, W. Coosemans, D. Van Raemdonck, B. Dillemans, P. De Leyn, J. M. Marnette, K. Geboes, and S. b. T. R. DeMeester
Surgical treatment of Barrett's carcinomaCorrelations between morphologic findings and prognosis
J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1059 - 1066.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.